229 related articles for article (PubMed ID: 24715704)
21. Oscillating devices for airway clearance in people with cystic fibrosis.
Morrison L; Milroy S
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD006842. PubMed ID: 32352564
[TBL] [Abstract][Full Text] [Related]
22. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Higgins C; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012040. PubMed ID: 28102546
[TBL] [Abstract][Full Text] [Related]
23. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
24. Oscillating devices for airway clearance in people with cystic fibrosis.
Morrison L; Innes S
Cochrane Database Syst Rev; 2017 May; 5(5):CD006842. PubMed ID: 28471492
[TBL] [Abstract][Full Text] [Related]
25. Nebulised hypertonic saline for cystic fibrosis.
Wark PA; McDonald V
Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
[TBL] [Abstract][Full Text] [Related]
26. Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM; Welch K; Smith S
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001915. PubMed ID: 31271656
[TBL] [Abstract][Full Text] [Related]
27. Nebulised hypertonic saline for cystic fibrosis.
Wark PA; McDonald V; Jones AP
Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863
[TBL] [Abstract][Full Text] [Related]
28. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
[TBL] [Abstract][Full Text] [Related]
29. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Tan KH
Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
[TBL] [Abstract][Full Text] [Related]
30. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
[TBL] [Abstract][Full Text] [Related]
31. Timing of hypertonic saline inhalation for cystic fibrosis.
Elkins M; Dentice R
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008816. PubMed ID: 32107770
[TBL] [Abstract][Full Text] [Related]
32. Autogenic drainage for airway clearance in cystic fibrosis.
McCormack P; Burnham P; Southern KW
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009595. PubMed ID: 28984368
[TBL] [Abstract][Full Text] [Related]
33. Macrolide antibiotics for cystic fibrosis.
Southern KW; Barker PM; Solis A
Cochrane Database Syst Rev; 2003; (3):CD002203. PubMed ID: 12917924
[TBL] [Abstract][Full Text] [Related]
34. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
Elkins MR; Jones A; van der Schans C
Cochrane Database Syst Rev; 2006 Apr; (2):CD003147. PubMed ID: 16625571
[TBL] [Abstract][Full Text] [Related]
35. Oscillating devices for airway clearance in people with cystic fibrosis.
Morrison L; Agnew J
Cochrane Database Syst Rev; 2014 Jul; (7):CD006842. PubMed ID: 25038719
[TBL] [Abstract][Full Text] [Related]
36. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2007 Oct; (4):CD001505. PubMed ID: 17943753
[TBL] [Abstract][Full Text] [Related]
37. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2016 Apr; 4():CD001505. PubMed ID: 27055154
[TBL] [Abstract][Full Text] [Related]
38. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012040. PubMed ID: 36866921
[TBL] [Abstract][Full Text] [Related]
39. Long-acting inhaled bronchodilators for cystic fibrosis.
Smith S; Edwards CT
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012102. PubMed ID: 29253920
[TBL] [Abstract][Full Text] [Related]
40. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD001505. PubMed ID: 31499593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
